Optimizing empiric antibiotic therapy in patients with severe β-lactam allergy. - Wikidata - wikimedia - TriplyDB

Optimizing empiric antibiotic therapy in patients with severe β-lactam allergy.

Optimizing empiric antibiotic therapy in patients with severe β-lactam allergy.

http://www.wikidata.org/entity/Q37335712

about

Stratification of the impact of inappropriate empirical antimicrobial therapy for Gram-negative bloodstream infections by predicted prognosis Prediction of Fluoroquinolone Resistance in Gram-Negative Bacteria Causing Bloodstream Infections.The 3 Cs of Antibiotic Allergy-Classification, Cross-Reactivity, and Collaboration.Predicting Resistance to Piperacillin-Tazobactam, Cefepime and Meropenem in Septic Patients With Bloodstream Infection Due to Gram-Negative Bacteria.Development of Institutional Guidelines for Management of Gram-Negative Bloodstream Infections: Incorporating Local Evidence.Impact of Penicillin Allergy on Empirical Carbapenem Use in Gram-Negative Bloodstream Infections: An Antimicrobial Stewardship Opportunity.

P2860

Q34922307-7AA1B37D-A10D-4017-A42A-1A502369D4E6 Q36729974-B99D6323-534F-4ACE-91D1-3719E3D29E45 Q38637036-FEEF2A39-94CF-4B05-993C-686D5EFD9959 Q47654446-D52581DD-A97C-4E15-A8B0-A4991DEC9A4A Q49587319-49F5C1A3-5231-43C1-8567-D5F32E043359 Q50145400-AB1969D5-DE60-47C3-AF78-597D200DE1F8

P2860

Optimizing empiric antibiotic therapy in patients with severe β-lactam allergy.

http://www.wikidata.org/entity/Q37335712

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 16 September 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Optimizing empiric antibiotic therapy in patients with severe β-lactam allergy.

@en

Optimizing empiric antibiotic therapy in patients with severe β-lactam allergy.

@nl

type

label

Optimizing empiric antibiotic therapy in patients with severe β-lactam allergy.

@en

Optimizing empiric antibiotic therapy in patients with severe β-lactam allergy.

@nl

prefLabel

Optimizing empiric antibiotic therapy in patients with severe β-lactam allergy.

@en

Optimizing empiric antibiotic therapy in patients with severe β-lactam allergy.

@nl

P1433

Q37335712-A2CEE476-D939-4620-800C-A9C0B5A172FE

P1476

Q37335712-BCA22E54-6B57-40C4-A728-98BEE6C59B41

P2093

Q37335712-14ED8B48-932C-4F38-ACF7-455083E1E971

Q37335712-30CD473D-D48B-4AFD-830C-3679C6079D7B

Q37335712-4D363313-DED7-460A-B391-B5F34ACA5F1D

Q37335712-7AEBE6DB-2733-4862-B757-383939251DF1

Q37335712-7F564DE5-E1F8-438A-B117-929E8479E162

Q37335712-92B1D536-BE47-43A4-A283-D506CF62FBFC

Q37335712-B7DB7158-7B9C-4334-93DE-2F2711934CB9

P2860

Q37335712-084F6088-02B5-4B0B-9D2C-6F6549A61996

Q37335712-0A22B88B-6F9D-48EE-979F-81271FEBD3A1

Q37335712-26D27A46-0D1B-40B5-AF58-7424E7525338

Q37335712-423DC4C2-01D3-4A7D-9F51-886512AD7940

Q37335712-475ADD8F-129A-4AF0-BC9A-F80E6F35CD62

Q37335712-57819917-B8ED-4DE2-B82D-2B0FF1302869

Q37335712-696972B4-A2F7-4D43-9F13-59869C442B78

Q37335712-87FA57F7-CFFF-42B2-AFA5-05BCB19A05E9

Q37335712-90B8D584-25A2-4E69-9988-00A4CC3F43E1

Q37335712-91D5ED9B-3770-4152-99D5-39D47A369E82

P304

Q37335712-C4CE1C74-36BD-4363-B40A-ADB772DBB9BA

P31

Q37335712-725BB2D0-79A9-4EE2-974A-1F8FB2305292

P356

Q37335712-675579AF-85CF-4450-BC6A-7AE5D54134C7

P407

Q37335712-99F6C00A-3409-4CAF-8209-96A7500A4825

P433

Q37335712-964147BE-FAC9-4DBA-8EBA-3D2F2FA404A0

P478

Q37335712-A3DFC99B-E9FD-4A2A-BB70-BC5C007874A4

P577

Q37335712-C0B7F6A0-2078-4399-A944-44E60C8FB3BA

P5875

Q37335712-C3B8A8D1-B020-4636-8F2D-342BB8BC9B52

P698

Q37335712-82699F2E-4E25-49FC-80F7-392BB212108E

P932

Q37335712-DD1332D0-AD40-4682-870C-8814400C4231

P356

P1433

Antimicrobial Agents and Chemotherapy

P1476

Optimizing empiric antibiotic therapy in patients with severe β-lactam allergy.

@en

P2093

Christopher A Ohl

http://www.w3.org/2001/XMLSchema#string

David P Miller

http://www.w3.org/2001/XMLSchema#string

James R Beardsley

http://www.w3.org/2001/XMLSchema#string

James W Johnson

http://www.w3.org/2001/XMLSchema#string

John C Williamson

http://www.w3.org/2001/XMLSchema#string

Lindsey P Koliscak

http://www.w3.org/2001/XMLSchema#string

Vera P Luther

http://www.w3.org/2001/XMLSchema#string

P2860

Guidelines for the Management of Adults with Hospital-acquired, Ventilator-associated, and Healthcare-associated Pneumonia

Using local microbiologic data to develop institution-specific guidelines for the treatment of hospital-acquired pneumonia.

Clinical practice. Antibiotic allergy.

Impact of BAL data on the therapy and outcome of ventilator-associated pneumonia.

Allergic cross-sensitivity between penicillin, carbapenem, and monobactam antibiotics: what are the chances?

Trends in antimicrobial resistance in intensive care units in the United States.

Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients.

Immediate hypersensitivity reactions to beta-lactam antibiotics.

Predictors of 30-day mortality and hospital costs in patients with ventilator-associated pneumonia attributed to potentially antibiotic-resistant gram-negative bacteria.

Optimizing empirical antimicrobial therapy for infection due to gram-negative pathogens in the intensive care unit: utility of a combination antibiogram.

P304

5918-5923

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.01202-13

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

57

http://www.w3.org/2001/XMLSchema#string

P577

2013-09-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

256664845

http://www.w3.org/2001/XMLSchema#string

P698

24041892

http://www.w3.org/2001/XMLSchema#string

P932

3837866

http://www.w3.org/2001/XMLSchema#string